Burney Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.59M Sell
24,418
-1,094
-4% -$116K 0.09% 192
2025
Q1
$3.17M Buy
25,512
+1,672
+7% +$208K 0.12% 165
2024
Q4
$2.94M Buy
23,840
+4,079
+21% +$502K 0.1% 178
2024
Q3
$2.2M Sell
19,761
-62
-0.3% -$6.91K 0.08% 209
2024
Q2
$2.12M Buy
19,823
+377
+2% +$40.2K 0.08% 219
2024
Q1
$2.34M Sell
19,446
-19,687
-50% -$2.37M 0.09% 212
2023
Q4
$4.81M Buy
39,133
+16,438
+72% +$2.02M 0.2% 133
2023
Q3
$2.94M Buy
22,695
+19,089
+529% +$2.47M 0.14% 176
2023
Q2
$447K Sell
3,606
-12,160
-77% -$1.51M 0.02% 426
2023
Q1
$2.31M Buy
15,766
+6,486
+70% +$949K 0.11% 205
2022
Q4
$1.48M Sell
9,280
-669
-7% -$107K 0.07% 247
2022
Q3
$1.33M Sell
9,949
-183
-2% -$24.4K 0.07% 254
2022
Q2
$1.58M Sell
10,132
-620
-6% -$96.7K 0.08% 230
2022
Q1
$1.67M Sell
10,752
-498
-4% -$77.5K 0.08% 260
2021
Q4
$1.43M Sell
11,250
-2,847
-20% -$363K 0.06% 275
2021
Q3
$1.84M Sell
14,097
-2,967
-17% -$386K 0.09% 236
2021
Q2
$3.03M Buy
17,064
+248
+1% +$44.1K 0.14% 180
2021
Q1
$2.76M Buy
16,816
+234
+1% +$38.5K 0.14% 185
2020
Q4
$2.74M Sell
16,582
-419
-2% -$69.2K 0.15% 173
2020
Q3
$2.42M Sell
17,001
-2,015
-11% -$287K 0.15% 187
2020
Q2
$2.1M Buy
19,016
+1,844
+11% +$203K 0.14% 186
2020
Q1
$1.71M Sell
17,172
-240
-1% -$23.9K 0.13% 180
2019
Q4
$2.6M Buy
17,412
+13,506
+346% +$2.02M 0.14% 165
2019
Q3
$501K Sell
3,906
-476
-11% -$61.1K 0.03% 317
2019
Q2
$625K Sell
4,382
-6,489
-60% -$926K 0.04% 309
2019
Q1
$1.55M Sell
10,871
-11,987
-52% -$1.71M 0.1% 214
2018
Q4
$2.83M Buy
22,858
+11,894
+108% +$1.47M 0.2% 145
2018
Q3
$1.84M Buy
+10,964
New +$1.84M 0.11% 203
2015
Q3
Sell
-2,560
Closed -$451K 384
2015
Q2
$451K Sell
2,560
-165
-6% -$29.1K 0.03% 288
2015
Q1
$471K Buy
2,725
+235
+9% +$40.6K 0.03% 290
2014
Q4
$408K Buy
2,490
+795
+47% +$130K 0.03% 296
2014
Q3
$272K Sell
1,695
-250
-13% -$40.1K 0.02% 349
2014
Q2
$286K Hold
1,945
0.02% 355
2014
Q1
$270K Buy
1,945
+100
+5% +$13.9K 0.02% 355
2013
Q4
$234K Buy
+1,845
New +$234K 0.02% 383